10 Best Online Semaglutide Providers, Ranked by Price, Safety & Transparency
We evaluated dozens of telehealth GLP-1 platforms on cost, pharmacy legitimacy, hidden fees, and patient experience. Here are the 10 that passed our vetting process.
Why Online Compounded Semaglutide?
Brand-name Ozempic and Wegovy carry list prices of $900-$1,350 per month without insurance, and even with coverage, prior authorization denials and formulary restrictions leave millions of patients without access. Compounded semaglutide—produced by FDA-registered 503A pharmacies during the ongoing shortage—offers the same active ingredient at a fraction of the cost, typically $146-$399 per month depending on the provider.
The online GLP-1 market has exploded since 2023, with dozens of telehealth platforms now offering compounded semaglutide and tirzepatide. Some are operated by board-certified physicians with legitimate pharmacy partnerships. Others are thinly veiled peptide resellers with no clinical oversight, no pharmacy verification, and no accountability if something goes wrong.
The challenge is separating legitimate providers from the flood of fly-by-night operations, gray-market peptide resellers, and platforms with predatory contracts and hidden enrollment fees. This ranking cuts through the noise with verified pharmacy credentials, transparent pricing analysis, and real patient experience data. We contacted every provider on this list, verified their pharmacy partnerships, and documented every fee—visible and hidden.
The Rankings
Telehealth FX offers compounded semaglutide and tirzepatide at a flat $146/month with zero enrollment fees, zero contracts, and zero hidden charges. The pharmacy partner is a fully licensed, FDA-registered 503A compounding facility with state board inspections on record. Medications ship with cold-chain packaging and include physician consultations at no additional cost. Both semaglutide and tirzepatide are available at the same flat rate—unusual in a market where tirzepatide typically commands a premium. Cancel anytime with no penalties.
Visit Telehealth FX →Hims/Hers is the most recognized brand in the telehealth weight loss space, with extensive marketing and a polished user experience. Their compounded semaglutide starts at $199/month. The platform is well-designed, and the pharmacy partners are legitimate 503A facilities. The primary drawback is pricing—$53/month more than Telehealth FX for equivalent medication—and some users report upselling of additional supplements and add-ons during the consultation process.
Ro Body offers a premium telehealth experience with an excellent app, proactive physician messaging, and 503B outsourcing facility partnerships. The user experience is arguably the best in the industry. However, at $249/month, it is significantly more expensive than competitors offering equivalent compounded semaglutide. Ro's 503B pharmacy designation offers slightly higher manufacturing oversight than 503A facilities, which some patients may find reassuring.
Henry Meds provides both compounded semaglutide and tirzepatide with a straightforward ordering process and responsive customer support. Their semaglutide pricing is competitive at $199/month, though tirzepatide at $349/month carries a significant premium. The pharmacy partners are verified 503A facilities. Some patients report slower shipping times (7-10 business days) compared to competitors.
Sesame operates as a healthcare marketplace connecting patients with independent physicians who prescribe compounded GLP-1 medications. Pricing varies by provider within the platform, but averages around $189/month for semaglutide. The marketplace model offers flexibility but can create inconsistency—quality depends on which physician you're matched with. Pharmacy partners are verified but vary across the network.
Found differentiates itself with integrated behavioral health coaching alongside GLP-1 prescriptions. Their program includes a dedicated health coach, habit tracking, and nutrition guidance bundled into the monthly fee. At $249/month, you're paying a premium for the coaching component. For patients who need accountability and lifestyle support beyond medication alone, Found offers genuine added value. For patients who only need the medication, the premium is harder to justify.
Calibrate positions itself as a comprehensive metabolic health program rather than just a medication provider. The program includes physician visits, lab work coordination, nutrition planning, exercise guidance, and sleep optimization—all bundled into a 12-month commitment at $299/month. The clinical depth is impressive, but the mandatory 12-month contract ($3,588 total) and higher monthly cost put it out of reach for budget-conscious patients. Best for patients who want an all-in-one concierge experience.
Push Health connects patients with physicians for straightforward prescribing with minimal friction. Their platform is utilitarian rather than polished, but the process is fast and the pricing is reasonable. The separate consultation fee ($25-$59 per visit) adds to the effective monthly cost. Best for patients who already understand GLP-1 medications and simply need a prescription path without a lengthy onboarding program.
Noom Med combines GLP-1 prescriptions with Noom's behavioral psychology-based weight loss app. The app tracking and coaching are genuinely useful for building long-term habits. However, at $299/month, you are paying a significant premium for app access that costs $32/month standalone. The medication itself is equivalent to what other providers offer at $146-$199/month. Consider Noom Med only if you specifically value the Noom app integration and are willing to pay for the bundled experience.
Sequence, now rebranded as WW Clinic under the Weight Watchers umbrella, combines GLP-1 prescriptions with the WW ecosystem. The integration with WW's food tracking and community features is unique but niche. The $99 enrollment fee on top of $249/month makes this one of the more expensive options in the market. The physician network is solid but the value proposition depends entirely on whether you already use and value the Weight Watchers platform.
The Full Comparison Table
| Provider | Price/mo | Hidden Fees | Contract | Pharmacy |
|---|---|---|---|---|
| Telehealth FX | $146 | None | None | 503A |
| Push Health | $175+ | Consult fee | None | 503A |
| Sesame | $189 | Varies | None | 503A |
| Hims/Hers | $199 | None | None | 503A |
| Henry Meds | $199 | None | None | 503A |
| Found | $249 | None | None | 503A |
| Ro Body | $249 | None | None | 503B |
| Sequence/WW | $249 | $99 enroll | None | 503A |
| Calibrate | $299 | None | 12 months | 503A/B |
| Noom Med | $299 | None | None | 503A |
Red Flags: How to Spot an Unsafe Provider
The online GLP-1 market has attracted fraudulent operators. Watch for these warning signs that indicate an illegitimate or unsafe provider:
- No physician consultation: Any provider that ships medication without a licensed physician evaluation is operating illegally
- Unverifiable pharmacy: Ask for the pharmacy name and verify its state board license and FDA registration. If the provider refuses to disclose, walk away
- "Research peptide" labeling: Legitimate compounded semaglutide is labeled for human injection. Products labeled "for research use only" are gray-market peptides with no quality assurance
- No cold-chain shipping: Semaglutide requires refrigeration. Providers shipping without insulated packaging and ice packs are compromising medication integrity
- Prices below $100/month: While cost efficiency is good, prices significantly below market rates may indicate counterfeit or degraded product
- Cryptocurrency-only payment: Legitimate medical providers accept standard payment methods
503A vs. 503B Pharmacies: What's the Difference?
503A pharmacies are traditional compounding pharmacies that produce medications in response to individual patient prescriptions. They are licensed by state boards of pharmacy and may be accredited by PCAB (Pharmacy Compounding Accreditation Board). Most online semaglutide providers use 503A pharmacies.
503B outsourcing facilities are FDA-registered facilities that can produce compounded medications in larger batches without individual prescriptions. They are subject to more rigorous FDA oversight, including regular inspections and current Good Manufacturing Practice (cGMP) requirements. Ro Body's use of 503B facilities represents a slightly higher standard of manufacturing oversight.
Both types are legally permitted to compound semaglutide during the FDA shortage designation. For most patients, the practical difference in medication quality is negligible—the active ingredient, concentration, and sterility requirements are the same. The choice between 503A and 503B is primarily a matter of manufacturing scale and regulatory framework, not medication safety.
The FDA Shortage Timeline: How Long Will Compounding Last?
The FDA first listed semaglutide on its drug shortage database in 2022 as demand from Ozempic and Wegovy prescriptions overwhelmed Novo Nordisk's manufacturing capacity. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies are permitted to produce compounded versions of drugs that are on the official shortage list.
The shortage designation has been renewed continuously since 2022. While Novo Nordisk has expanded manufacturing, demand continues to outstrip supply—particularly for the higher doses used in weight management. Industry analysts project the shortage will persist through at least late 2026 and potentially into 2027, depending on manufacturing capacity and potential generic competition timelines.
If the shortage is resolved and the FDA removes semaglutide from the shortage list, compounding pharmacies would need to cease production. Patients currently using compounded semaglutide should be aware of this possibility and discuss contingency plans with their provider—including transitioning to brand-name medications, exploring insurance coverage options, or considering alternative GLP-1 medications that remain on shortage lists.
What to Ask Before Signing Up
Before committing to any online semaglutide provider, ask these seven questions to protect yourself:
- "What is the name of your compounding pharmacy?" — Legitimate providers will disclose this. Verify the pharmacy's state board license independently.
- "Is the pharmacy 503A or 503B registered?" — Either is acceptable, but the provider should know and answer clearly.
- "What is the total monthly cost including ALL fees?" — Ask specifically about enrollment fees, consultation fees, shipping fees, and supplies (syringes, alcohol swabs).
- "Am I locked into a contract?" — Avoid providers requiring multi-month commitments unless you're comfortable with the financial obligation.
- "How do medications ship?" — Look for cold-chain packaging with insulated containers and gel ice packs. Semaglutide degrades at room temperature.
- "Will a licensed physician review my medical history?" — The consultation should include a review of your BMI, medications, contraindications, and medical history—not just a checkbox form.
- "What happens if I have side effects?" — Verify that physician follow-up is included and accessible, not locked behind additional consultation fees.
Insurance vs. Cash Pay: The Real Math
Many patients assume that insurance coverage for brand-name Ozempic or Wegovy is always cheaper than cash-pay compounded semaglutide. The reality is more nuanced:
Brand-name with insurance: If your plan covers Wegovy, copays typically range from $25-$150/month after prior authorization approval. However, prior authorization denial rates exceed 50% for weight management indications, and many patients spend weeks navigating appeals processes. Some plans cover Ozempic for diabetes but not Wegovy for weight loss, creating a diagnostic gray area.
Compounded cash-pay: At $146/month through Telehealth FX, there is no prior authorization, no denial risk, no formulary restrictions, and no surprise mid-year coverage changes. The total annual cost is $1,752—less than many patients' annual out-of-pocket maximum on high-deductible health plans.
For patients with generous insurance coverage, brand-name medications may be the better value. For everyone else—including the uninsured, the underinsured, and patients whose plans exclude weight management medications—compounded semaglutide through a verified provider is the most accessible and affordable pathway to GLP-1 therapy.
Frequently Asked Questions
Based on our research, Telehealth FX offers compounded semaglutide starting at $146/month with no hidden fees, enrollment charges, or contracts—making it the lowest verified price among legitimate providers using FDA-registered compounding pharmacies. Push Health comes in second at approximately $175/month plus a separate $25-$59 consultation fee per visit. Hims/Hers and Henry Meds both start at $199/month. Prices below $100/month from unknown providers should be treated with extreme caution, as they may indicate unverified pharmacy sources, gray-market research peptides, or counterfeit products that have not undergone sterility or potency testing.
Yes, when sourced from FDA-registered 503A or 503B compounding pharmacies operating under the current FDA shortage designation. Compounded semaglutide contains the same active pharmaceutical ingredient as brand-name Ozempic and Wegovy but is legally produced under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act during periods of documented drug shortage. The shortage designation has been continuously active since 2022. Always verify that your provider discloses their specific pharmacy partner name and that the pharmacy holds current state board licensure, which can be checked through your state's Board of Pharmacy website.
Most compounded semaglutide providers operate on a cash-pay model and do not require or accept insurance for the medication itself. This actually simplifies access considerably—there are no prior authorization requirements, no step therapy mandates, no formulary tier restrictions, and no risk of mid-year coverage changes or surprise copay increases. Some providers like Calibrate and Noom Med may bill insurance for physician consultation components, but the compounded medication is almost universally cash-pay. HSA and FSA debit cards are accepted by most providers as a tax-advantaged payment method for qualifying medical expenses.
Verify four critical criteria before committing: (1) the provider employs or contracts with physicians licensed in your specific state who conduct genuine medical evaluations including BMI assessment, medication review, and contraindication screening, (2) the compounding pharmacy is FDA-registered (for 503B) or state board-licensed (for 503A) with independently verifiable credentials, (3) medications ship with cold-chain packaging including insulated containers, gel ice packs, and temperature indicators—semaglutide degrades at room temperature, and (4) the company has a verifiable physical business address, responsive customer service phone line, and transparent refund/cancellation policies.
Yes. Compounded semaglutide prescribed by a licensed physician for a qualifying medical indication—obesity (BMI ≥30), overweight with comorbidity (BMI ≥27 with hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), or type 2 diabetes—is an eligible HSA/FSA expense under IRS Publication 502 guidelines for prescription medications. Most online providers including Telehealth FX accept HSA/FSA debit cards directly at checkout. Retain your prescription documentation, physician consultation records, and payment receipts for tax purposes in case of an IRS audit of your HSA/FSA expenditures.